Shreds of evidence from preclinical and clinical studies have shown persistent elevation in various inflammatory markers like TNF-α, IL-12, IL-1β, IL-6, IL-1, and interferon (IFN)-γ in first onset and acute relapse schizophrenia subjects who were on antipsychotic medications (Miller et al. 2011). The gene discussed is IFNG; the disease is schizophrenia.